Griffith Named U.S. House E&C Committee’s Health Subcommittee Chair, 340B Critic Harshbarger Elevated to Vice Chair

U.S. Rep. Morgan Griffith (R-Va.) will take over as chairman of the House E&C Health Subcommittee, while U.S. Rep Diana Harshbarger (R-Tenn.) will become the panel’s new vice chair.
A Virginia Republican is set to replace longtime 340B critic U.S. Rep. Earl “Buddy” Carter (R-Ga.) as the chair of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Oregon Law Lets Health Centers Report 340B Claims Through Clearinghouse Instead of PBMs

A new Oregon law grants certain covered entities new flexibility in how they report 340B claims involving PBMs.
Oregon has enacted a new law granting health centers and certain grantees more flexibility in how they report 340B claims [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

AbbVie was among five drugmakers to announce new state exemptions to their 340B contract pharmacy restrictions in early July.
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Slam Newly Enacted GOP Budget Law Over Deep Medicaid Cuts

President Donald Trump on July 4 signed a reconciliation bill with controversial Medicaid cuts that providers strongly criticized.
Provider groups are sharply criticizing the newly enacted, GOP-backed budget reconciliation bill, warning that its more than $1 trillion in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Senate Amends 340B Contract Pharmacy Access Bill to Add Provider Reporting, Audit Requirements

The California Senate Health Committee recently amended a 340B contract pharmacy access bill to add new audit and reporting requirements.
California state senators have amended new provider reporting and auditing requirements onto a bill barring drugmakers from placing 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Condemn Reconciliation Bill’s Medicaid Cuts, Urge Lawmakers to Reject Ahead of Final House Vote

Hospital and health center advocates cautioned that the “One Big Beautiful Bill” would have devastating effects on providers—many of whom already struggle with financial uncertainty—and the Medicaid patients they serve.
Hospital and health care provider advocates this week once again urged federal lawmakers to reject a controversial GOP-backed reconciliation plan [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rep. Buddy Carter to Step Down as House E&C Health Subcommittee Chair

U.S. Rep. Earl “Buddy” Carter (R-Ga.) announced Wednesday that he was stepping down as chairman of the House Energy & Commerce Committee’s Health Subcommittee.
The head of a key U.S. House subcommittee that oversees 340B drug pricing program policy issues is leaving the chairmanship [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Oklahoma Over New 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis each filed federal lawsuits challenging Oklahoma's 340B contract pharamcy access law.
Two large drug companies this week filed federal lawsuits seeking to strike down Oklahoma’s new law prohibiting drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ohio Becomes Ninth State to Enact 340B Provider Reporting Law

Ohio Gov. Mike DeWine (R) on June 30 endorsed a state budget bill that included 340B provider reporting requirements.
Ohio Gov. Mike DeWine (R) last night endorsed a sweeping $60 billion budget bill with new 340B provider reporting requirements—but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live